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As public microarray repositories rapidly accumulate gene expression data, these resources contain
increasingly valuable information about cellular processes in human biology. This presents a unique
opportunity for intelligent data mining methods to extract information about the transcriptional modules
underlying these biological processes. Modeling cellular gene expression as a combination of functional
modules, we use independent component analysis (ICA) to derive 423 fundamental components of
human biology from a 9395-array compendium of heterogeneous expression data. Annotation using
the Gene Ontology (GO) suggests that while some of these components represent known biological mod-
ules, others may describe biology not well characterized by existing manually-curated ontologies. In
order to understand the biological functions represented by these modules, we investigate the mecha-
nism of the preclinical anti-cancer drug parthenolide (PTL) by analyzing the differential expression of
our fundamental components. Our method correctly identiﬁes known pathways and predicts that N-gly-
can biosynthesis and T-cell receptor signaling may contribute to PTL response. The fundamental gene
modules we describe have the potential to provide pathway-level insight into new gene expression
datasets.
 2010 Elsevier Inc. All rights reserved.1. Introduction
The wide use of high-throughput DNA microarray technology
promises to provide an increasingly detailed view of the human
transcriptome in many different contexts. As experimentalists con-
tinue to sample a variety of biological conditions and cell types,
public gene expression repositories grow exponentially: the Gene
Expression Omnibus (GEO), the largest of these databases, now
contains over 400,000 individual microarrays (www.ncbi.nlm.nih.
gov/geo/). Although biomedical researchers typically design micro-
array experiments to explore speciﬁc biological contexts, meta-
analyses that integrate data from multiple experiments have the
potential to reveal relationships that are not accessible through
any individual dataset [1–10]. One critical question in the post-
genomic era is the identiﬁcation of sets of functionally related
genes that correspond to a particular biological process. While cu-
rated databases such as the Gene Ontology (GO) group genes with
related functions, these resources are necessarily incomplete and
prone to human error [11]. Furthermore, GO categories do not nec-
essarily correspond to co-regulated transcriptional units [12].
Computational methods based on co-expression, therefore, havell rights reserved.
ve S172, MC: 5444, Stanford,
tman).the potential to enhance the identiﬁcation of genes that contribute
to the same biological processes [1,7,13]. Given the wide sampling
of diverse cellular conditions, a meta-analysis of human gene
expression data should yield information about many of the key
pathways and processes in human biology.
Methods that extract gene expression modules (subsets of
genes that are co-regulated across subsets of conditions) provide
a means for identifying functionally related genes from microarray
data [13–21]. Popular methods for this analysis, such as hierarchi-
cal clustering, k-means clustering, and self-organizing maps
(SOMs), identify disjoint sets of genes that are co-expressed
throughout a particular dataset. Because these approaches require
that genes belong to only one transcriptional module, however,
they do not capture an important feature of gene regulation: it is
common for the same proteins to serve different functions depend-
ing on biological context [22]. Furthermore, simple clustering ap-
proaches may be inappropriate for large-scale gene expression
meta-analysis because they capture global signals in the compen-
dium and exclude more speciﬁc signals [23]. These challenges have
led to methods like biclustering that simultaneously cluster sub-
sets of genes over subsets of conditions [23–25].
For a more biologically relevant model for gene expression,
researchers often turn to matrix decomposition methods [19,25–
32]. Gene expression data lends itself to representation as a matrix,
with columns corresponding to genes and rows corresponding to
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improvement over traditional clustering methods by modeling
microarray data as a combination of biological modules that can
share genes. Furthermore, matrix decomposition provides a gener-
ative model that allows for uniﬁed analysis of multiple datasets.
One common method, principal component analysis (PCA), pro-
vides a representation of microarray data in terms of a set of line-
arly uncorrelated axes [26,27]. Each axis, or principal component,
explains the maximal variance not represented by the previous,
orthogonal components. While PCA can identify interesting biolog-
ical information, its linear transformation involves only second or-
der statistics; like clustering methods based on co-expression, PCA
may miss more complex relationships between genes [31]. Fur-
thermore, the application of PCA to biological data assumes that
gene expression follows a multivariate normal distribution. Recent
studies demonstrate that microarray gene expression measure-
ments typically follow a super-Gaussian distribution [33,34], sug-
gesting that PCA applies a model that does not accurately reﬂect
our knowledge of biology.
Independent component analysis (ICA), in contrast, provides a
more biologically plausible model for gene expression data by
assuming non-Gaussian data distributions. A blind source separa-
tion algorithm, ICA models observations as a linear combination
of latent feature variables, or components, which are chosen to
be as statistically independent as possible. For microarray data,
observations consist of microarray gene expression measurements,
and independent components are interpreted to be transcriptional
modules that often correspond to speciﬁc biological processes [28].
ICA has proven successful in a variety of biological inquiries,
including identifying oscillating regulatory modules in yeast cell
cycle data [28], investigating tumor-related pathways [35–39],
classifying disease datasets [40,41], characterizing transcriptional
regulators [42,43], identifying disease-speciﬁc biomarkers [44],
and examining response to bacterial infection [45]. Furthermore,
ICA outperforms PCA and other unsupervised methods in identify-
ing co-regulated and biologically relevant gene modules in diverse
datasets [31,39]. Although ICA produces stochastic component
estimates with different initial conditions, clustering and averaging
the results from multiple runs can yield robust independent com-
ponent estimates [38,45]. While previous applications of ICA to
microarray data have used at most hundreds of experiments, no
large-scale meta-analysis to identify fundamental gene modules
has been attempted.
Compared with resources such as the Gene Ontology, ICA pro-
vides a data-driven method for exploring functional relationships
and grouping genes into transcriptional modules. We apply ICA
to a large microarray compendium initially comprised of 9395
microarrays representing a diverse set of experimental conditions
and cell types. We identify 423 fundamental components (FCs) of
human biology, and show that these components yield gene
expression modules with coherent functions. To evaluate the bio-
logical relevance of our fundamental components, we develop a
method to perform differential expression analysis in the feature-
space described by our FCs.
Using this technique, we assess the ability of our method to
identify known mechanisms of parthenolide (PTL), a preclinical
drug under investigation for its ability to selectively induce apop-
tosis in multiple cancer types [46–50]. Known PTL effects can be
divided into two intracellular signals. First, PTL induces oxidative
stress, evidenced by increased levels of reactive oxygen species
[51] and activation of c-Jun N-terminal kinase (JNK) [52]. Second,
PTL inhibits inﬂammatory responses via inhibition of STAT3 [53]
and the transcription factor NF-jB [54,55]. PTL treatment leads
to apoptosis in various cancer cell lines [46,51], and activation of
p53 has been associated with the AML-speciﬁc apoptosis mecha-
nism [46]. We show that independent components derived froma diverse compendium offer module-level insight into transcrip-
tional response that cannot be gleaned from the PTL dataset alone.
2. Methods
2.1. Creation of the human gene expression compendium
We downloaded our microarray compendium from the Gene
Expression Omnibus (GEO) [56], selecting all GEO Series (GSEs)
run on the Affymetrix Human Genome U133 Plus 2.0 array (GEO
accession GPL570) available on May 28, 2008. We ﬁltered these ar-
rays to remove samples that represented species other than hu-
man, and we removed GSEs with missing data so that imputation
was not necessary. Normalized microarray data are often uploaded
to GEO, but we downloaded only unprocessed CEL ﬁles in order to
standardize the normalization procedures across all arrays in the
compendium. After applying these ﬁlters, the resulting dataset
consisted of 298 GEO Series comprised of 9395 arrays.
We applied a two-step normalization pipeline as previously de-
scribed [10]. For each series, we aggregated and normalized probe
level information using robust multi-array average (RMA) [57],
transformed each expression value using log base 2, and removed
technical bias resulting from variation in hybridization conditions
and starting material using the R package bias 0.0.3 [58]. This with-
in-series normalization identiﬁed probe or arrays outliers within
each dataset. We mapped probes to genes using the Bioconductor
annotation package hgu133plus2 1.16.0 [59], and calculated
expression values for each gene by averaging the values of probe-
sets measuring the same gene. Finally, we performed quantile nor-
malization [60] on the entire compendium using the limma R
package (version 2.18.2) [61] in order to reconcile broader differ-
ences between datatsets and ensure that all arrays were on the
same scale prior to applying ICA. This produced a compendium
comprising 20,099 genes and 9395 arrays.
To reduce the contributions of over-represented conditions, and
to eliminate rare signals that the compendium did not sample suf-
ﬁciently, we grouped similar arrays using hierarchical clustering.
First, we centered and scaled the expression values within an array,
and centered the expression values for each gene. We calculated
pairwise correlations between arrays using Spearman’s rank corre-
lation coefﬁcient, r, a metric robust to outliers that performs well
with microarray data [62,63]. We deﬁned pairwise distances, d, by
dx;y ¼ 1 jrx;yj; ð1Þ
where x and y are the gene expression measurements of individual
microarrays. Using these distances, we applied agglomerative hier-
archical clustering to the compendium using average linkage. To ﬁl-
ter the resulting clusters, we required that nodes pass two cutoffs.
First, in order to cap the heterogeneity of arrays within a cluster,
we empirically limited the maximum pairwise intra-cluster dis-
tance, dmax, to 0.3. Second, in order to eliminate conditions or sig-
nals that did not have sufﬁcient representation within the
compendium, we required a minimum cluster size, cmin, of 5. We
generated representative nodes for clusters that passed these cut-
offs by using average linkage to calculate centroids. We called these
representative cluster nodes ‘‘meta-samples”, and combined them
to create a meta-compendium that reduced the dimensionality of
the data. We examined the sensitivity of the meta-compendium
and independent components extracted to the parameters dmax
and cmin and found that our results were robust with different
parameters (data not shown).
2.2. Iterated FastICA
ICA identiﬁes latent variables, or independent components, that
provide a new set of basis vectors for a dataset. In other words, ICA
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ture-space identiﬁed by independent components. As opposed to
gene modules, which typically consist of unordered subsets of
genes, components contain scores for each gene in the domain.
To extract a robust set of independent components from the
meta-compendium, we applied iterated ICA and averaged the re-
sults. Here we brieﬂy describe the ICA model; for a more thorough
review of the procedural details of the application of ICA to micro-
array data, see Kong et al. [64].
Let X represent the m  n matrix of microarray data measuring
the expression of n genes in m experiments. ICA models this
expression matrix as a linear combination of independent biologi-
cal processes by decomposing X into a k  n source matrix S and a
m  k mixing matrix A such that X = AS, where k is a user-supplied
parameter no greater than the minimum of m and n. For our anal-
yses, we set k =m to extract the maximum number of components
from the meta-compendium. These components, or rows of S, are
independent in the sense that the gene weights in each component
reﬂect samplings of independent random variables. In the context
of gene expression, this suggests that the sets of genes comprising
the groups strongly contributing to each component have indepen-
dent compositions. We performed ICA using the R interface to the
FastICA algorithm (version 1.1–11), which attempts to maximize
the non-Gaussianity of the component distributions [65]. For
microarray data, these distributions are typically super-Gaussian:
only a small number of genes contribute heavily to a speciﬁc bio-
logical process, while the majority of genes do not contribute
[28]. We used the contrast function
gðuÞ ¼ log coshu ð2Þ
and allowed a convergence tolerance of 0.0001. To account for the
stochastic nature of ICA, we ran the algorithm 20 times and pooled
the independent component estimates in a method similar to the
Icasso software [66]. We clustered component estimates with par-
titioning around medoids [67], a robust version of k-means, using
the distance metric based on Spearman’s correlation coefﬁcient in
Eq. (1). We deﬁned the fundamental components (FCs) of our anal-
ysis as the k medoids that result from this clustering analysis. To
visualize the independent component estimates, we used classical
multi-dimensional scaling to represent the 20,099-dimension com-
ponent matrix in two dimensions.
2.3. Functional annotation of fundamental components
To examine the biological processes associated with each com-
ponent, we made use of two sources of information yielded by the
ICA decomposition: the distribution of gene weights in a compo-
nent (rows of S), and the distribution of a component’s expression
in arrays in the compendium (columns of A).
2.3.1. Annotation based on component gene weight distributions
The rows of the source matrix, S, describe the contributions of
individual genes to each component. Each component contains
an expression value for each gene. ICA produces components with
unit variance and zero mean, so the contributions of each gene are
relative. We call the genes that signiﬁcantly contribute to each
component the active genes, and identiﬁed them by using a weight
threshold [37] of three standard deviations from the mean. Similar
to Lee and Batzoglou [31], we generated two sets of active genes
for each component: one for genes with positive loadings and
one for genes with negative loadings. Our initial observations, as
well as those of Frigyesi et al. [38], suggested that this division re-
sults in a greater number of signiﬁcant annotations. For a given
component, we called the module with more genes the dominant
module. Since the signs of independent component expression val-ues are arbitrary, we reoriented each component so that the load-
ings for the dominant module were positive.
To investigate the biological functions of our fundamental com-
ponents, we used Alexa et al.’s elim algorithm [68] to identify en-
riched biological process GO categories in the active gene
modules, assessing signiﬁcance with Fisher’s exact test. We anno-
tated each gene cluster with GO categories with a Bonferroni-cor-
rected p-value <0.05. To further characterize the biological
processes associated with each component, we identiﬁed signiﬁ-
cant canonical pathways using Ingenuity Pathway Analysis (Inge-
nuity Systems, www.ingenuity.com). Ingenuity uses Fisher’s
exact test to calculate a p-value determining the probability that
the association between genes in the dataset and the canonical
pathway is explained by chance alone. We deﬁned signiﬁcant
pathways as those with a p-value <0.05 after correcting for false
discovery rate with the Benjamini–Hochberg method.
2.3.2. Annotation based on component expression in compendium
Independent components provide an orthogonal basis with
which to describe the original data, so we modeled each original
experiment as a linear combination of FCs. To generate a mixing
matrix that describes the original arrays, we projected the full
9395-array compendium into the feature-space deﬁned by the
FCs using Eq. (3)
A ¼ XST ð3Þ
This resulted in an (array  component) mixing matrix, A,
whose columns describe the contributions of a component to each
array in the compendium. A high absolute weight in this matrix for
component i and array j indicates that the gene expression pattern
present in component i plays a signiﬁcant role in deﬁning the
expression proﬁle of array j. Because component expression forms
complex distributions [37], we annotated each FC with the 100
individual arrays in the compendium that have the highest expres-
sion of that component. In other words, we found the 100 arrays
with the highest scores in each column of A, which we called the
active arrays. The active arrays deﬁne the context in which a gene
module is expressed. We annotated each gene module with the
GEO Series containing the active arrays, ordering the GSEs by the
number of active arrays contributed by each series.
2.4. Differential expression analysis of parthenolide
From the full compendium, we selected and normalized
GSE7538, a dataset consisting of 12 pairs of PTL-treated or untreated
primary acutemyelogenous leukemia (AML) specimens [8].Wepro-
jected this datasetonto thebasis vectorsdeﬁnedbyour fundamental
components [Eq. (3)] to determine the levels of component expres-
sion in each array. Analogous to the use of differential expression
analysis to identify differentially expressed (DE) genes of interest,
weused thequantitativeexpression levels of components to identify
DE components. Speciﬁcally, we applied the linear modeling and
empirical Bayesmethods of the limma 2.18.2 R package [61] to iden-
tify differentially expressed components between treated and un-
treated AML samples. To compare this approach with existing DE
gene identiﬁcationmethods,we used themoderated t-statistic from
limma to identifyDEgenes fromtheoriginal dataset.Wealso applied
ICAto thePTLdatasetalone,using themethodologydescribed inSec-
tion 2.2, to identify the maximum possible number of independent
components (24 components). Using only the data from GSE7538,
we again used linear modeling to identify DE components. For each
comparison, we adjusted the p-values for differential expression
using the Benjamini–Hochberg correction.Weexamined geneswith
p-valuesbelow0.05 and componentswithp-valuesbelow0.001.We
also restricted our search to components whose differential expres-
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strategy might eliminate true signal, it also removes inconsistent
patterns that may represent heterogeneity within the tumors.
2.5. Identiﬁcation of novel regulators of parthenolide response
To identify novel regulators of parthenolide response, we used
the dominant gene modules from DE components to create protein
interactions networks with Ingenuity Pathway Analysis (Ingenuity
Systems, www.ingenuity.com). Ingenuity overlaid active genes
onto a global molecular network developed from information con-
tained in Ingenuity’s Knowledge Base, and it algorithmically gener-
ated networks based on gene connectivity. We ranked genes in
order of connectivity, and examined the highly-connected hub
genes. To generate a list of known PTL-associated genes, we used
the Pharmspresso text-mining tool to search the biomedical litera-
ture [69]. Pharmspresso searched all 322 PubMed articles with
‘‘parthenolide” in the title or abstract looking for co-occurrences
of the term ‘‘parthenolide” with gene names in the same sentence,
and obtained a list of 363 known PTL-associated genes.
3. Results
3.1. Identiﬁcation of fundamental components of human biology
Our starting compendium consisted of 20,099 genes measured
by 9395 heterogeneous arrays, representing 298 GEO Series (GSEs)
that spanned a wide range of human biology. While a majority of
these data series contributed fewer than 15 arrays, we noticed that
the ﬁve largest GSEs constituted over one third of the total arrays
in the compendium. For instance, GSE2109 contributed 1974 pri-
mary tumor samples from various sources and GSE8052 contrib-
uted 404 lymphoblastoid samples from an asthma study. A
compendium-wide analysis using Spearman’s rank correlation as
a similarity metric revealed strong correlations within datasets
and between experiments performed with similar cell types and
conditions (Supplementary Fig. 1). We reasoned that the dispro-
portionate representation of some transcriptional patterns might
cause certain biological conditions to dominate the ICA results.
At the same time, we did not wish for rare gene expression pat-
terns caused by extreme experimental perturbations or technical
errors to skew the compendium. Therefore, to reduce the contribu-
tions of over-represented conditions and to eliminate cellular sig-
natures that were not replicated within the compendium, we
applied a ﬁlter based on hierarchical clustering to the original com-
pendium (Fig. 1). The resulting meta-compendium consisted ofFig. 1. Clustering procedure applied to subset of compendium. To reduce the contribut
hierarchical clustering using a distance metric based on Spearman’s rank correlation to th
cluster distance of 0.3 and a minimum size of 5. We selected 323 neuron samples that c
from the original compendium (left) clustered together to form meta-samples (right) wit
compendium because they did not satisfy our cluster selection criteria: they might repr423 meta-samples that included contributions from 5818 of the
original arrays.
We next applied iterated ICA to the meta-compendium to iden-
tify 423 fundamental components that span a wide range of hu-
man biology. Since ICA produces components in an arbitrary
order, we sorted the components based on the amount of variance
of the meta-compendium they explain (Supplementary Fig. 2). Un-
like PCA, ICA does not use variance explained as a criterion to select
components. Still, ordering components based on this metric may
provide biologically relevant information [28]: fundamental com-
ponents that explain a large percentage of the variance in a com-
pendium represent processes that are active in many biological
or experimental conditions, while those that explain a relatively
small percentage of the variance represent relatively infrequent
transcriptional patterns that are active only under certain condi-
tions. In this ordering scheme, the ﬁrst independent component
explained 3.2% of the variance in the meta-compendium. Over
multiple runs, ICA reliably reproduced the 10 components that ex-
plain the most variance (Fig. 2A). To verify that low-ranking com-
ponents also clustered together, we examined a sampling of
components that explained varying fractions of the variance in
the data (Fig. 2B). Signals appeared robust even for the less well-
represented components. Henceforth, we refer to components by
their rank in this ordering. That is, fundamental component 1
(FC-1) explains the most variance in the meta-compendium, while
FC-423 explains the least.
To investigate whether our method of meta-compendium crea-
tion succeeded in reducing the contributions of over-represented
conditions, we compared the percentage of variance explained by
each FC in the meta-compendium to that in the original compen-
dium (Supplementary Fig. 3). Some FCs explain more variance in
the meta-compendium than in the original compendium; these
FCs may represent relatively rare but reproducible biology that
was up-weighted in the meta-compendium. Many FCs, however,
explain 1.5- to 3-fold less variance in the meta-compendium, and
may represent biology that was over-sampled in the original com-
pendium. We examined the active array clusters for two represen-
tative FCs, 62 and 268, selected for their high reduction in variance
explained and their relative separation in the component ordering
(Supplementary Fig. 3). FC-62 explains 1.26% of the variance in the
full compendium but only 0.31% of the variance in the meta-com-
pendium, and the 100 arrays with the highest expression of the
component all are part of GSE8052, the 404-array asthma study
mentioned previously (Supplementary Fig. 1). Similarly, the 100
arrays with the highest expression for FC-268 consist entirely of
brain samples from a single GEO series. Since FC-268 explainsions of highly replicated conditions in the compendium, we applied agglomerative
e full compendium, then selected and consolidated clusters with a maximum intra-
lustered together to graphically demonstrate this preprocessing step. Experiments
h corresponding colors. We excluded samples with black lines (left) from the meta-
esent extreme experimental perturbations or technical errors.
Fig. 2. Independent component estimates with GO Biological Process annotations. We applied ICA to the meta-compendium using 20 different random seeds to obtain
423  20 = 8460 component estimates. We clustered these estimates using partitioning around medoids and deﬁned the 423 medoids as the fundamental components. We
plotted a 2-D projection of the component estimates for (A) the 10 components that explain the most variance in the meta-compendium and (B) a range of high- to low-
ranking components that explain different amounts of variance in the meta-compendium. Colored numbers represent component ranks when ordered by variance explained.
Fig. 3. Correlation between variance explained and enriched GO categories. We
analyzed the active genes in the two modules associated with each FC and plotted
the total number of enriched GO categories for a component versus the fraction of
variance explained. Some FCs that explain a small percentage of variance have
many enriched GO categories, suggesting that they represent rare but relevant
expression proﬁles.
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an over-sampled gene expression signature that does not play a
large role in most biological conditions.
3.2. Functional annotation of fundamental components
To examine the biological processes and functions associated
with each component, we made use of two sources of information
yielded by ICA decomposition: the distribution of gene weights in a
component, and the distribution of component expression in ar-
rays in the compendium. First, to identify genes that contribute
signiﬁcantly to each component, we used a loading cut-off of 3.0,
corresponding to three standard deviations above the zero mean.
For each component we created two gene modules, one for signif-
icant genes with positive loadings and one for negative loadings.
The mean module size was 155.95, with a standard deviation of
73.57, although typically one module associated with a component
was larger than the other; the mean difference between the sizes of
a component’s modules was 110.00, with a standard deviation of
80.57. For a particular component, we refer to the module with
more genes as the dominant module. 14,932 out of 20,009 genes
belong to at least one module. We then calculated GO category
enrichment in the active gene sets. 292 out of the 423 FCs had en-
riched GO categories in at least one of the two active gene modules.
Supplementary Table 1 shows the enriched GO categories for the
dominant modules of the ﬁrst 10 components. We observed a
weak correlation between the amount of variance explained by a
FC and the total number of enriched GO categories found for its ac-
tive genes (Fig. 3). However, in accordance with Roden et al.’s
observations with PCA [70], many FCs that explain less than 0.5%
of variance in the compendium have strong GO annotation. This
suggests that these FCs explain relatively infrequent but biologi-
cally coherent transcriptional patterns.
3.3. Differential expression analysis of parthenolide treatment
response
To assess the utility of our fundamental components, we ana-
lyzed a dataset from the initial compendium (GEO accession
GSE7538) using three methods: (1) standard differential geneexpression analysis, (2) differential expression analysis based on
independent components derived from the dataset alone, and (3)
differential expression analysis using FCs derived from the full
compendium of data. GSE7538 contains acute myelogenous leuke-
mia (AML) CD34+ cells from 12 patients treated with parthenolide
(PTL), a sesquiterpene lactone with anti-inﬂammatory and anti-
cancer activities [46,47].
Linear modeling with empirical Bayes methods in gene-space
identiﬁed 2574 differentially expressed (DE) genes at a signiﬁcance
level <0.05 after correcting for multiple hypothesis testing, and we
annotated this set of genes with signiﬁcant GO categories and
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with higher scores when separating the genes into up-regulated
and down-regulated sets, so we present those results here. The sig-
niﬁcant pathways identiﬁed from the genes up-regulated in PTL-
treated CD34+ AML cells included NRF2-mediated oxidative stress
response, hypoxia signaling in the cardiovascular system, and pro-
tein ubiquitination pathway (Table 1), all of which are consistent
with oxidative stress-induced apoptosis caused by parthenolide.
Differential expression analysis in gene-space also marked gluco-
corticoid receptor signaling, which is related to the NF-jB signaling
pathway [71,72].
Next we applied iterative ICA to the 24-experiment data series,
identifying 24 independent components. We projected the data
into this feature-space, and identiﬁed one signiﬁcant DE compo-
nent that explains 31.6% of the variability between treated and un-
treated cells. This method predicted that the protein ubiquitination
pathway and NRF2-mediated oxidative stress response are up-reg-
ulated with increased signiﬁcance compared to the gene-space
analysis (Table 1). GO enrichment analysis in this feature-spaceTable 1
Enriched pathways for DE genes and DE experiment-speciﬁc independent
components.*
Experiment Annotation p-Value
DE gene analysis Ingenuity canonical pathways
(up-regulated)
Protein ubiquitination pathway 8.51E03
NRF2-mediated oxidative stress
response
8.51E03
Hypoxia signaling in the
cardiovascular system
8.51E03
Polyamine regulation in colon
cancer
1.51E02
Glucocorticoid receptor
signaling
1.51E02
GO categories (up-regulated)
Organ development 4.87E15
Multicellular organismal
process
3.94E09
Cell–cell signaling 1.18E07
System process 3.00E07
Signal transduction 1.38E05
Ingenuity canonical pathways
(down-regulated)
None
GO categories (down-regulated)
Generation of precursor
metabolites and energy
1.87E10
Cell surface receptor linked
signal transduction
6.89E09
Blood circulation 2.51E08
Regulation of multicellular
organismal process
1.33E07
Positive regulation of biological
process
3.59E07
Experiment-speciﬁc DE
component analysis
Ingenuity canonical pathways
(up-regulated)
NRF2-mediated oxidative stress
response
2.95E09
Protein ubiquitination pathway 7.59E03
Hypoxia signaling in the
cardiovascular system
7.59E03
Inositol metabolism 1.10E02
Polyamine regulation in colon
cancer
1.91E02
GO categories (up-regulated)
Response to unfolded protein 1.77E12
Protein folding 4.63E09
* p-Values for ingenuity canonical pathways have Benjamini–Hochberg correction
applied. p-Values for GO categories have Bonferroni correction applied.did not yield as many enriched GO categories as the same analysis
in gene-space (Supplementary Tables 2 and 3).
Finally we analyzed the differential expression in response to
PTL treatment in terms of our fundamental components. We pro-
jected the original dataset into FC-space and identiﬁed 29 DE com-
ponents with a p-value threshold of 0.001. To eliminate signals
reﬂecting parthenolide response heterogeneity, we limited our re-
sults to the 19 components that were regulated in the same direc-
tion in all 12 paired samples (Fig. 4). Unlike DE analysis using
independent components from GSE7538 alone, no FC explained a
large fraction of differential expression as compared to the others;
rather, complex manipulations of a wide range of gene modules
contributed to the expression changes between PTL-treated and
untreated cells. In addition to GO enrichment and Ingenuity Path-
way Analysis, we identiﬁed for each DE component the experi-
ments that contain arrays with the highest expression scores for
that component.
Although neither gene-space nor experiment-speciﬁc feature-
space analysis identiﬁed NF-jB as a signiﬁcant pathway in PTL re-
sponse, FC-space analysis identiﬁed NF-jB signaling as the top
pathway associated with FC-66, the fundamental component with
the greatest differential expression (Table 2). FC-66 was also en-
riched for JAK/Stat signaling and SAPK/JNK signaling (Supplemen-
tary Table 4), two pathways with known associations with PTL
response [52,53]. Listing the experiments that highly express this
component revealed that FC-66 plays an important role in leuke-
mia (Table 2). In the second most over-expressed fundamental
component, FC-362, NRF2-mediated oxidative stress response
appeared at the top of the list of enriched Ingenuity pathways,
echoing the ﬁndings in gene-space and experiment-speciﬁc com-
ponent-space and matching previous experimental results [51].
Intriguingly, N-glycan biosynthesis appeared at the top of the list
for the third most over-expressed fundamental component, FC-
84. Subsets of glycan structures have speciﬁc functions that affect
cell differentiation, growth and migration, and have been impli-
cated with cancer development and metastasis [73]. Of the three
most under-expressed FCs, only FC-62 offered descriptive GO cat-
egories and Ingenuity pathways. The dominant gene module for
this component showed enrichment for EIF2 Signaling, and a closer
examination of the gene list for this module revealed a preponder-
ance of ribosomal proteins. This suggests that PTL modulates trans-Fig. 4. Nineteen differentially expressed fundamental components between PTL-
treated and untreated AML CD34+ cells, sorted by relative fold change. Expression
units are arbitrary due to normalization and scaling.
Table 2
Annotations for six DE fundamental components with the highest absolute expression change.*
Component (Dexpr)** Annotation p-Value
66 Ingenuity canonical pathways
(+3.11) NF-jB signaling 8.51E03
T-cell receptor signaling 8.51E03
Type I diabetes mellitus signaling 8.51E03
IL-6 signaling 1.51E02
Glucocorticoid receptor signaling 1.51E02
GO categories
Regulation of transcription, DNA-dependent 2.76E06
Negative regulation of biological process 4.23E02
GEO experiments with high expression of this component
GSE10609 The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-ALL
GSE7440 Early Response and Outcome in High-Risk Childhood Acute Lymphoblastic Leukemia: A Children’s Oncology Group Study
GSE10358 Discovery and validation of expression data for the Genomics of Acute Myeloid Leukemia Program at Washington University
GSE10792 Genome wide genotyping and gene expression data of childhood B-cell precursor ALL without known genetic aberrations
GSE7757 Robustness of gene expression signatures in leukemia: comparison of three distinct total RNA preparation procedures
362 Ingenuity canonical pathways
(+2.34) NRF2-mediated oxidative stress response 1.05E04
Complement system 1.23E02
Aryl hydrocarbon receptor signaling 1.23E02
Glucocorticoid receptor signaling 2.40E02
Role of pattern recognition receptors in recognition of bacteria and viruses 2.40E02
GO categories
Response to unfolded protein 1.67E15
Protein folding 2.86E15
Organ development 4.48E02
GEO experiments with high expression of this component
GSE7307 Human body index – transcriptional proﬁling
GSE7621 Expression data of substantia nigra from postmortem human brain of Parkinson’s disease patients (PD)
GSE10315 Multipotent mesenchymal stromal cells: identiﬁcation of pathways common to TGFb3/BMP2-induced chondrogenesis
GSE8977 Bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis
GSE2816 cMyb and vMyb in human monocytes
84 Ingenuity canonical pathways
(+1.53) N-glycan biosynthesis 3.38E10
Endoplasmic reticulum stress pathway 1.23E04
NRF2-mediated oxidative stress response 1.23E02
antigen presentation pathway 1.72E02
Lipid antigen presentation by CD1 3.03E02
GO categories
Protein folding 4.92E10
Protein amino acid N-linked glycosylation 2.46E07
Secretion 6.40E05
Intracellular protein transport 2.26E04
Cell redox homeostasis 2.90E04
GEO experiments with high expression of this component
GSE10315 Multipotent mesenchymal stromal cells: identiﬁcation of pathways common to TGFb3/BMP2-induced chondrogenesis
GSE6283 Speciﬁc transcriptional changes in human fetus with autosomal trisomies
GSE6400 Cultured A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050
GSE6241 The effects of Serum Amyloid A on gene expression proﬁle in HUVECs
GSE7846 Differentially expressed genes in HEECs of eutopic endometrium of patients with endometriosis compared with control
208 Ingenuity canonical pathways
(1.73) None
GO categories
None
GEO experiments with high expression of this component
GSE2109 Expression Project for Oncology (expO)
GSE10609 The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-ALL
GSE9891 Expression proﬁle of 285 ovarian tumor samples
GSE6532 Deﬁnition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade
GSE9151 Allergen induced gene expression of airway epithelial cells shows a possible role for TNF-a
62 Ingenuity canonical pathways
(1.95) EIF2 signaling 1.91E10
Regulation of eIF4 and p70S6K signaling 3.89E08
mTOR signaling 3.72E04
GO categories
Translation <1E-30
Translational elongation 3.99E05
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Table 2 (continued)
Component (Dexpr)** Annotation p-Value
Regulation of translational initiation 4.18E04
Ribonucleoprotein complex biogenesis 3.64E03
GEO experiments with high expression of this component
GSE10358 Discovery and validation of expression data for the Genomics of Acute Myeloid Leukemia Program at Washington University
GSE10609 The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-ALL
GSE2109 Expression Project for Oncology (expO)
GSE10792 Genome wide genotyping and gene expression data of childhood B-cell precursor ALL without known genetic aberrations
GSE7307 Human body index – transcriptional proﬁling
101 Ingenuity canonical pathways
(2.68) None
GO categories
Defense response 2.22E03
Icosanoid biosynthetic process 5.91E03
Immune system process 8.37E03
GEO experiments with high expression of this component
GSE10358 Discovery and validation of expression data for the Genomics of Acute Myeloid Leukemia Program at Washington University
GSE7757 Robustness of gene expression signatures in leukemia: comparison of three distinct total RNA preparation procedures
GSE8023 AML1-ETO transduced human cord blood cells, CD34 selected, compared to normal cord blood cells, CD34 selected
* Only the top ﬁve annotations in each category are shown. For a full list, see Supplementary Table 4. p-Values for ingenuity canonical pathways have Benjamini–Hochberg
correction applied. p-Values for GO categories have Bonferroni correction applied.
** A positive expression change indicates that the component is up-regulated in PTL-treated compared to untreated.
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the increase in reactive oxygen species.
Unexpectedly, FC-66 was over-expressed in PTL-treated sam-
ples, seemingly countering current belief that PTL inhibits NF-jB
activation. To determine the reason for this apparent reversal, we
examined the expression of genes in the Ingenuity NF-jB Signaling
pathway for both FC-66 (Fig. 5) and the original data from GSE7538
(Supplementary Fig. 4). This analysis revealed that genes in the NF-
jB pathway exhibit a wide range of transcriptional changes in
response to parthenolide, regardless of whether the genes play
inhibitory or stimulatory roles. In the original data, IjBa (NIKBIA),
an inhibitor of the NF-jB complex, is down-regulated in PTL-trea-
ted samples, while other components of inhibitory complexes are
up-regulated (IjBb, IjBe). Similarly, subunits of the NF-jB
complex itself show varied transcriptional responses. However,
the direct target of PTL, IKKb (IKBKB), had a negative loading in
FC-66 and was down-regulated in PTL-treated compared to un-
treated cells, suggesting that transcription-level regulation and
protein-level activation are coordinated for this key gene in parthe-
nolide response.
To explore the biological validity of our method’s predictions on
the gene-level as well as the module-level, we created a protein
interaction network from the dominant module of each differen-
tially expressed FC. For each FC, we ranked genes by connectivity
in this network, since highly-connected proteins, or hub genes,
are likely more essential to biological function and survival [74–
76] and potentially represent therapeutic targets [77]. We deﬁned
our hub genes as the most highly-connected 1% of the 3278 genes
active in at least one of the 19 DE components, yielding a list of 32
highly-connected genes (Table 3). To identify novel predictions, we
compared this list of hub genes to our text-mined catalog of known
PTL-associated genes. Fourteen of the 32 hub genes appear on this
text-mined list, including key regulators of PTL response such as
TNF, NFKB1, STAT4 and FOS.
Among the genes not on the Pharmspresso list, several appear
to represent known genes that the text-mining algorithm did not
detect. C/EBP-b (CEBPB), for instance, is a transcription factor that
interacts with a known PTL-associated gene, C/EBP-a (CEBPA),
whose loss of function leads to the development of AML [78].
Kawasaki et al. found that regulatory targets of C/EBP-b are differ-
entially expressed in PTL-treated prostate cancer cells [79]. HGF,although not previously directly linked to PTL, depends on the
STAT pathway for HGF/SF-Met mediated tumorigenesis [80], and
so may be linked to the PTL response mechanism.
Other genes on this list may represent new genes and pathways
involved in PTL response. CNBP and EIF3A both contribute to FC-
62, whose dominant gene module is associated with protein trans-
lation. CNBP plays a role in controlling proliferation and cell
survival, for instance by regulating the CT element of the c-myc
protooncogene [81]. A group of highly-connected proteins – LCK,
ZAP70, LAT, CD247 and CD3E – contribute to the T-cell receptor
signaling pathway in FC-43 (Supplementary Table 4). Some of
these genes also appear in the NF-jB Signaling pathway (Fig. 5).
Lewis and coworkers reported aberrant expression of T-cell mark-
ers in AML [82], and an independent microarray study implicated
T-cell receptor signaling in AML stem cell function [83], suggesting
that expression of this pathway may be relevant to AML response
to PTL.4. Discussion
To develop a data-driven view of the human transcriptome, the
biological community needs analysis tools that leverage the grow-
ing repositories of gene expression data. We assembled a large
cross-study compendium of human microarray data and extracted
fundamental components of human biology using independent
component analysis. These components described gene modules
that have biologically coherent functions, and we used them to im-
prove the differential expression analysis of a microarray dataset
involving the preclinical drug parthenolide (PTL).
Because we identiﬁed gene modules through a meta-analysis of
expression data from GEO, our analysis depends fundamentally on
the quality of the primary microarray data. Variation in hybridiza-
tion conditions and starting mRNA quantity and quality could
introduce spurious signals whose origins are technical rather than
biological. To address this issue, we applied the technical bias cor-
rection proposed by Eklund and Szallasi [58] to all GEO data. Our
initial compendium also reﬂected a non-uniform sampling of hu-
man biology due to biases in the biological conditions commonly
investigated (Supplementary Fig. 1). In a study to mine functional
gene relationships from a large microarray compendium, Hutten-
Fig. 5. FC-66 expression of the Ingenuity NF-jB Signaling canonical pathway. Ingenuity software overlaid gene expression loadings from FC-66 onto a pre-designed pathway.
Red = over-expressed in PTL-treated versus untreated, green = under-expressed.
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over-representation of certain biological or experimental condi-
tions [84]. Similarly, we wished to derive a broad but even sam-
pling of human biology; we did not want our fundamental
components to describe a disproportional number of pathways un-
ique to cancer, for example. We applied a grouping method based
on hierarchical clustering to create a meta-compendium that
down-weighted the contributions from over-represented condi-
tions and eliminated expression proﬁles that did not appear repro-
ducibly in the compendium. In the process, we averagedmicroarray proﬁles within the same cluster, possibly removing
information about some of the less well-represented transcrip-
tional subunits present within datasets. However, we wanted to fo-
cus on modules active in multiple experiments throughout our
collection, so we chose to retain well-represented transcriptional
processes at the expense of less well-represented ones.
Additionally, this procedure for normalizing the weights of dif-
ferent biological conditions resulted in the removal of over 3000
arrays. Of these arrays, approximately 1900 of them consisted of
tumor samples derived from a single compilation dataset (GEO
Table 3
32 hub genes from DE fundamental components in PTL-treated
versus untreated AML CD34+ cells.*
Connections Gene FC(s)
47 XBP1 84
33 TNF 66
30 LCK 43
25,14,11 CEBPB 192,362,406
21 IL1B 101
18,13 CEBPA 101,406
16 ZAP70 43
15 CNBP 62
15 CD40LG 43
14,11 FOS 62,359
14 IL1A 73
14 IL10 406
14 HGF 406
13 HSPA8 362
13 HLA-B 84
12 HSPA5 84
12 NFKB1 66
11,10 EP300 66,406
11,9 STAT4 66,43
11 HSP90AA1 362
11 LAT 43
11 CD28 43
10 IL15 406
10 CD247 43
10 CD3E 43
9 PTGS2 101
9 EIF3A 62
9 HSP90AB1 362
9 CD2 43
9 VEGFA 79
9 MMP9 79
8 CREM 66
* Bold indicates a gene that does not appear on the text-mined
list and thus represents a potentially novel prediction.
Fig. 6. Comparison of differential expression analysis of GSE7538 in gene- and
fundamental component feature-space. We deﬁned hub genes as the most highly-
connected 1% of the 3278 genes active in at least one of the differentially expressed
FCs. p-Values denote enrichment of known PTL-associated genes in each group,
calculated using the hypergeometric test. Fractions represent the number of known
PTL-associated genes and the total number of genes in each set (known/total).
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malization, the scope of our results depends on the sampling of
biology available.
In our analysis, we used ICA to identify gene modules that vary
together across our gene expression compendium. While Fehr-
mann et al. used principal component analysis (PCA) for a similar
analysis [21], ICA provides a complementary method for analyzing
gene expression data [31]. At the same time, ICA does not rely on
prior knowledge for identiﬁcation of gene modules; although prior
knowledge may enhance the analysis of well-studied biological
processes [16,29], we chose to use gene expression data alone to
guide the formation of our gene modules. In this context, ICA has
two major procedural limitations. First, the user must specify the
number of components to extract. Like other studies using ICA,
we searched for the maximum possible number of components
(423, the number of samples in the meta-compendium), assuming
that more biological processes exist than we can describe with this
number of sources [31]. Second, ICA is a stochastic algorithm. To
extract robust biological signals from the meta-compendium, we
repeated ICA twenty times. In contrast to approaches that mitigate
unstable signals by eliminating them entirely [37], we clustered
the results to obtain more reliable component estimates [66] using
partitioning around medoids. To maximize our ability to compre-
hensively model microarray data, we included all 423 components
in downstream analyses. One ﬁnal challenge associated with ma-
trix decomposition methods involved identifying active genes.
Although alternative methods exist [38], we followed the approach
of Liebermeister [28] and used a gene loading threshold.
To conﬁrm the biological relevance of these gene modules, we
devised a method to analyze differential expression in the fea-
ture-space deﬁned by our fundamental components. This followsnaturally from the typical assumption in work with ICA that the ac-
tive genes in each component are differentially expressed [28,35].
Although several groups have used principal component features
to enhance the detection of individual differentially expressed
genes [85] or gene pathways from GO and KEGG [86], the opportu-
nity to assess the differential expression of entire gene modules
has not been adequately explored. We exploited the component
loadings in the mixing matrix of the ICA decomposition and used
the moderated t test [61] to assess the differential expression of
globally-derived gene modules within a single dataset. Analysis
in feature-space reduced the number of statistical tests performed,
decreasing the need for multiple hypothesis testing correction and
increasing the sensitivity of biological signal detection [87]. We
empirically selected different p-value cutoffs for DE gene analysis
(p = 0.05) and DE component analysis (p = 0.001) to optimize the
performance of each method.
DE analysis in feature-space outperformed similar analysis in
gene-space, identifyingmore known PTL-associated genes as signif-
icant (Fig. 6). Additionally, the pathways enriched in differentially
expressed FCs proved to be highly consistent with previously char-
acterized PTL effects on cellular processes, identifying both NF-jB
signaling and oxidative stress as major mechanisms involved in re-
sponse to PTL treatment. Because we modeled a gene expression
proﬁle as a linear combination of components, however, we must
interpret pathwaypredictionswith care. An active gene in aDE com-
ponent may not necessarily be a DE gene in gene-space analysis. In
our investigation of the mechanism of parthenolide, FC-66 loadings
of genes in the NF-jB pathway did not necessarily mirror the
direction of regulation in differential gene expression analysis
(Supplementary Fig. 4). Complex gene networks such as the NF-jB
signaling pathway contain proteins with both inhibitory and stimu-
latory effects, so the ﬁnding that FC-66 was over-expressed in
PTL-treated cells did not necessarily indicate that the entire NF-jB
pathway was both transcriptionally and functionally up-regulated.
Rather, different genes responded to this stimulus according to their
role in the pathway (Fig. 5). As a further demonstration of this tran-
scriptional complexity, we note that our method identiﬁed the hub
gene Cox-2 (PTGS2) as differentially up-regulated in FC-406 and
down-regulated in FC-101 (data not shown). While we were unable
todetermine thenetdirection inwhichPTL response inﬂuencesCox-
2 expression, our result corroborates previous data suggesting that
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This demonstrates the enhanced sensitivity of our approach, as DE
analysis in gene-space did not identify Cox-2 as an important gene
in PTL response.
After deriving gene modules using a data-driven approach, we
used ontological annotations to provide a preliminary indication
of the functional relationships between active genes. We found
that for some of these gene modules, Ingenuity Pathway Analysis
provided more descriptive relationships between genes, especially
in the realm of signaling pathways (e.g. FC-66, Table 2). Our anal-
ysis of the mechanism of PTL, a drug that affects the NF-jB signal-
ing pathway, particularly beneﬁted from this form of annotation. In
other cases, GO Biological Process categories labeled components
where Ingenuity did not (e.g. FC-101, Table 2). Still, annotation of
our fundamental components with GO categories left 131 compo-
nents unlabeled, suggesting that GO does not completely describe
some functional gene relationships. Indeed, some of the DE funda-
mental components identiﬁed in our analysis of PTL had neither
descriptive GO categories nor signiﬁcant Ingenuity Pathways. FC-
208, for instance, was highly expressed in several cancer-related
experiments, but was down-regulated in response to PTL (Table
2). This gene module may represent a cancer-speciﬁc transcrip-
tional subunit that is suppressed by PTL. Similarly, FC-101 had va-
gue GO annotations including ‘‘defense response”, but was highly
expressed in three independent AML experiments (Table 2). The
three genes with the highest weights in FC-101 consisted of DNTT,
whose expression in AML cells correlates with outcome [90,91];
SOCS2, which is part of a gene signature prognostic for an unfavor-
able AML subtype [92]; and DDIT4, whose mRNA levels are in-
duced in AML cell lines and normal CD34+ cells during
differentiation [93]. Thus our method detected a transcriptional
subunit active in AML that is not adequately characterized by tra-
ditional functional analysis methods.
Since ICA deﬁnes components in a manner that allows a gene to
participate in more than one transcriptional module, our approach
also provides a mechanism for modeling context speciﬁcity [13].
As we highlighted using the example of Cox-2, our method deﬁnes
the functional role of a gene in the context of other genes. Given
the independence properties of components derived by ICA, we
interpret these results as deﬁning several speciﬁc contexts in
which each gene operates. Furthermore, since we can identify
experimental conditions that lead to the co-expression of sets of
genes, we can match gene modules with their biological contexts.
For example, the set of genes in the dominant module of FC-101
might be labeled as ‘‘up-regulated in AML” and ‘‘differentially ex-
pressed in PTL response”. This context awareness will prove
invaluable as we continue to explore the functional relationships
between genes at the genomic scale.5. Conclusion
As opposed to a top-down resource such as the Gene Ontology
(GO), we provide an entirely data-driven way to identify gene
modules in a meta-analysis of expression data using ICA. These
modules contain functionally coherent sets of genes and increase
the descriptive power of differential expression analysis. The re-
sults of our analysis of a parthenolide-related dataset suggests that
the fundamental components we have identiﬁed may serve as use-
ful, reusable features; although we applied these modules to exam-
ine a microarray experiment from our original compendium, we
can use the same components to investigate new expression data.
In addition to differential expression analysis, these gene modules
could serve as data-driven gene sets for Gene Set Enrichment Anal-
ysis [18] or as features for clustering and classifying diverse micro-
array expression data. Given the wide range of biological pathwaysrepresented in the compendium, these components could be
applied to query a microarray database for experiments that
modulate similar biological processes. Finally, we can use this
data-driven framework to annotate genes with context-speciﬁc
functional relationships.6. Availability
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